Trials / Completed
CompletedNCT00851500
A Trial of the Safety and Efficacy of K-604 for the Treatment of Atherosclerosis
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 210 (estimated)
- Sponsor
- Kowa Research Institute, Inc. · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the safety and efficacy of K-604 for the treatment of atherosclerosis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | K-604 | K-604 is given for 26 weeks |
| OTHER | Placebo | placebo tablets are given for 26 weeks |
Timeline
- Start date
- 2009-02-01
- Primary completion
- 2011-06-01
- Completion
- 2011-08-01
- First posted
- 2009-02-26
- Last updated
- 2011-08-17
Locations
19 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00851500. Inclusion in this directory is not an endorsement.